| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| NEUTRAL | NEUTRAL | NEUTRAL | NEUTRAL | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | N/A | N/A | N/A | N/A | N/A |
| MA10 | N/A | N/A | N/A | N/A | N/A |
| MA20 | N/A | N/A | N/A | N/A | N/A |
| MA50 | N/A | N/A | N/A | N/A | N/A |
| MA100 | N/A | N/A | N/A | N/A | N/A |
| MA200 | N/A | N/A | N/A | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | N/A | N/A | N/A | N/A | N/A |
| RSI | N/A | N/A | N/A | N/A | N/A |
| STOCH | N/A | N/A | N/A | N/A | N/A |
| WILL %R | N/A | N/A | N/A | N/A | N/A |
| CCI | N/A | N/A | N/A | N/A | N/A |
|
Monday, October 19, 2026 12:59 PM
Read today's latest Iambic Therapeutics (IAM) share news, written by our in-house team of expert financial journalists.
|
|
Saturday, October 17, 2026 05:16 PM
Iambic Therapeutics (IAM) was just added to the Nasdaq Composite Index after a busy October that included its US$150 million IPO and a US$184.6 million shelf registration. The recent Nasdaq Composite ...
|
|
Thursday, October 15, 2026 03:00 PM
Iambic Therapeutics, Inc. is a technology and clinical-stage life sciences company. Its molecular superintelligence platform integrates proprietary AI technologies with automated, ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 20/10/26 | 16.31 | 17.50 | 15.00 | 16.01 | 978,580 |
|
|
||||
|
|
||||
|
|